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Abstract 
Background: Gestational Diabetes Mellitus (GDM) is a risk factor for diabetes and 
cardiovascular diseases. Early detection of cardio-metabolic risks is recommended for 
management. This study evaluated the associations between Metabolic Syndrome (MetS), 
abnormal glucose tolerance and cardiovascular risk factors in Malaysian women with prior 
GDM. Method: Seventy-seven, non-diabetic women post-GDM, aged 20-40 years (mean 
BMI: 26.4 ± 4.6kg/m2) with high type 2 diabetes risks, were evaluated at a median of four 
months postpartum. Their anthropometric and biochemical measurements were obtained. 
Results: The overall prevalence of MetS and dysglycaemia were 22% and 29% respectively. 
Dysglycaemic was predominantly impaired glucose tolerance (IGT: 77%).MetS was higher 
among dysglycaemic subjects although also detected in 13% of normo glycaemic subjects. 
Eighty percent of IGT subjects did not have MetS. Sixty-eight percent of subjects had 
intermediate or high CVD risks (hsCRP>1mg/L). hscRP increased with obesity and was not 
associated with glycaemic status. Infant birth weight, maternal age and triglycerides were 
independent predictors of dysglycaemia (p<0.05). Conclusion: Despite the low prevalence of 
MetS, elevated levels of hsCRP among these women with prior- GDM was highly prevalent. 
Normoglycaemic subjects with MetS demonstrated intermediate to high risk hsCRP levels. 
The findings also emphasize the importance of performing OGTT mainly in older post-GDM 
women, with higher triglycerides and infants who are large for gestational age. 
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